This R13 application requests funds to partially (50%) support the Molecular Surgeon Symposium on Genetics and Genomics of Pancreatic Cancer, which will be the fourth time of the Molecular Surgeon Symposium series in the Baylor College of Medicine (BCM). The symposium will be held at the Texas Medical Center, Houston, Texas, on April 12 and 13, 2008. The overall goal of this interdisciplinary scientific symposium is to bring together scientists and physicians from diverse fields with a common interest in understanding Genetics and Genomics of Pancreatic Cancer. It will also provide a unique opportunity for trainees (postdoctoral fellows, clinical residents and fellows, medical students, and other scientists) to interact with investigators in the field of cancer research. This symposium is unique in that it will provide a forum for presenting and discussing the latest advances in pancreatic cancer research. ? ? This one and a half day symposium will consist of an opening keynote presentation with the following scientific sessions: 1). Genomic alterations in pancreatic cancer; 2). Gene expression alteration in pancreatic cancer; 3). Gene regulation and functions in pancreatic cancer-I (mouse model and k-ras gene); and 4). Gene regulation and functions in pancreatic cancer-II (Smad, XIST, CACAM6, mucin, mesothelin, SSTR, neuropilins, and PDX-1). In addition, poster session will be organized. ? ? Attendees will be invited to submit an abstract to poster section planned for the symposium that will allow all attendees, especially students, residents, and young investigators, to present their data and fully participate in discussions. We anticipate approximately 250 attendees. The limited attendance, focused scientific sessions, and highly successful poster session combined will provide an exciting forum for the exchange of ideas and will provide extensive opportunities for participation by a diverse group of scientists interested in pancreatic cancer. Funding is requested for planning and organizing the meeting and for travel and housing costs for speakers and those trainees selected for travel awards. Matching funds (50%) will be provided by the Institution to cover other costs. The Organizing/Scientific Committee will consist of members from research disciplines that represent the integrated/educational concept of the Symposium. At the conclusion of the symposium, participants should be able to: 1) understand the impact and opportunities of genetics and genomics on pancreatic cancer research; 2) discuss recent scientific advances related to molecular pathogenesis, diagnosis, and therapy for pancreatic cancer; 3) determine the future directions of pancreatic cancer research; and 4) establish a collaborative network in pancreatic cancer research. All presentations will be video-taped and presented on the """"""""The Molecular Surgeon"""""""" website for general public access (website has been established since 1999). Furthermore, invited speakers are encouraged to submit manuscripts related to their presentations to """"""""World Journal of Surgery"""""""" for consideration of publications. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Conference (R13)
Project #
1R13CA132572-01
Application #
7408620
Study Section
Special Emphasis Panel (ZCA1-GRB-A (O2))
Program Officer
Sharman, Anu
Project Start
2008-03-01
Project End
2009-02-28
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
1
Fiscal Year
2008
Total Cost
$5,000
Indirect Cost
Name
Baylor College of Medicine
Department
Surgery
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Donahue, Timothy R; Hines, O Joe (2009) CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer. World J Surg 33:710-5
Voidonikolas, Georgios; Gingras, Marie-Claude; Hodges, Sally et al. (2009) Developing a tissue resource to characterize the genome of pancreatic cancer. World J Surg 33:723-31
Marin-Muller, Christian; Li, Min; Chen, Changyi et al. (2009) Current understanding and potential immunotherapy for HIV-associated squamous cell carcinoma of the anus (SCCA). World J Surg 33:653-60
Templeton, Nancy Smyth (2009) Nonviral delivery for genomic therapy of cancer. World J Surg 33:685-97
Rodriguez, Joel A; Guiteau, Jacfranz J; Nazareth, Lynne et al. (2009) Sequencing the full-length of the phosphatase and tensin homolog (PTEN) gene in hepatocellular carcinoma (HCC) using the 454 GS20 and Illumina GA DNA sequencing platforms. World J Surg 33:647-52
Voidonikolas, Georgios; Kreml, Stephanie S; Chen, Changyi et al. (2009) Basic principles and technologies for deciphering the genetic map of cancer. World J Surg 33:615-29
Liang, Yulong; Lin, Shiaw-Yih; Brunicardi, F Charles et al. (2009) DNA damage response pathways in tumor suppression and cancer treatment. World J Surg 33:661-6
Patel, Sanjeet G; Zhou, Guisheng; Liu, Shi-He et al. (2009) Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas. World J Surg 33:630-7
Yang, Linda; Belaguli, Narasimhaswamy; Berger, David H (2009) MicroRNA and colorectal cancer. World J Surg 33:638-46
Firpo, Matthew A; Gay, David Z; Granger, Steven R et al. (2009) Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen. World J Surg 33:716-22

Showing the most recent 10 out of 12 publications